GlassScriptPhysician profile
Amy Burgett
NPI 1336246149
$1,852.94
in general payments reported to CMS, 2019-2025
30 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $445 · 2020: $168 · 2021: $298 · 2022: $413 · 2023: $261 · 2024: $165 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $529.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $528.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $320.30 | 2019-2025 | |
| Astellas Pharma US INC | $228.39 | 2019-2024 | Veozah |
| Abbvie INC. | $213.65 | 2019-2022 | |
| Therapeuticsmd, INC. | $197.27 | 2019-2022 | |
| Channel Medsystems, INC. | $118.78 | 2022 | |
| Mayne Pharma Commercial LLC | $109.14 | 2021-2024 | |
| Amgen INC. | $97.25 | 2019-2022 | |
| Exact Sciences Corporation | $77.95 | 2023-2024 | Cologuard Collection Kit |
| Pfizer INC. | $39.37 | 2022-2023 | |
| Allergan, INC. | $37.10 | 2019-2020 | |
| Agile Therapeutics, INC. | $29.14 | 2022 | |
| Glaxosmithkline, LLC. | $25.13 | 2019-2021 | |
| Roche Diagnostics Corporation | $24.61 | 2019 | |
| Daiichi Sankyo INC. | $23.76 | 2019 | |
| Hologic Sales and Service, LLC | $23.32 | 2023 | Thinprep 2000 Processor |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Duchesnay USA Incorporated | $23.11 | 2019 | |
| Myovant Sciences INC. | $22.52 | 2021 | |
| Exeltis, USA INC. | $22.37 | 2025 | Slynd |
| Minerva Surgical, INC | $22.24 | 2025 | |
| Organon LLC | $21.99 | 2025 | Nexplanon |
| Axonics, INC. | $21.10 | 2023 | Axonics |
| Lsi Solutions INC | $20.85 | 2024 | Fornisee |
| Radius Health, INC. | $20.24 | 2019 | |
| Scynexis, INC. | $19.82 | 2022 | |
| Merck Sharp & Dohme LLC | $17.53 | 2019 | |
| Sage Therapeutics, LLC | $16.11 | 2019 | |
| Convatec INC. | $15.57 | 2021 | |
| Evofem Biosciences, INC. | $15.16 | 2021 | |
| Millicent US INC | $15.08 | 2024 | Intrarosa |
| Amag Pharmaceuticals, INC. | $14.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Burgett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.